BioEnterics Intragastric Balloon: The Italian Experience with 2,515 Patients

摘要: Background: The temporary use of the BioEnterics Intragastric Balloon (BIB) in morbidly obesity is increasing worldwide. aim this study evaluation efficacy device a large population, terms weight loss and its influence on co-morbidities. Methods: Data were retrospectively recruited from data-base Italian Collaborative Study Group for Lap-Band BIB (GILB). After diagnostic endoscopy, was positioned filled with saline (500-700 ml) methylene blue (10 ml). Patients discharged diet counselling (~1000 Kcal) medical therapy. removed after 6 months. Positioning removal performed under conscious or unconscious sedation. Mortality, complications, BMI, %EWL, BMI co-morbidities evaluated. Results: From May 2000 to September 2004, 2,515 patients underwent (722M/1,793F; mean age 38.9±14.7, range 12-71; 44.4±7.8 kg/m 2 ; 28.0-79.1; excess 59.5±29.8 kg, 16-210). positioning uncomplicated all but two cases (0.08%) acute gastric dilation treated conservatively. Overall complication rate 70/2,515 (2.8%). Gastric perforation occurred 5 (0.19%), 4 whom had undergone previous surgery: died successfully by laparoscopic repair balloon removal. 19 obstructions (0.76%) presented first week rupture (n=9; 0.36%) not prevalent within any particular period treatment, also Esophagitis (n=32; 1.27%) ulcer (n=5; 0.2%) without history peptic disease conservatively drugs. Preoperative diagnosed 1,394/2,471 (56.4%); these resolved 617/1,394 (44.3%), improved (less pharmacological dosage shift other therapies) 625/1,394 (44.8%), unchanged 152/1,394 (10.9%). months, 35.4±11.8 (range 24-73) %EWL 33.9±18.7 0-87). 4.9±12.7 0-25). Conclusions: an effective procedure satisfactory improvement Previous surgery contraindication placement.